Skip To Main Content
Keneng Chen on Muck Rack

Keneng Chen

As seen in: JAMA Network
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Keneng Chen’s profile

Articles by Keneng Chen

Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non–Small Cell Lung Cancer : Post Hoc Analysis of the Neotorch Randomized Clinical Trial

|
By Wentao Fang, Yiyang Wang, Wenxiang Wang, Lin Wu, Longhua Sun, Peng Zhang, Shun Lu, Yan Zheng, Qixun Chen, Lijie Tan, Lin Yang, Jiandong Mei, Xiaohong Sun, Shidong Xu, Nong Yang, Dongliang Yu, Yuping Chen, Guohua Yu, Xiaohua Hu, Ligang Xing, Nan Wu, Hui Tian, xun zhang, Yunpeng Liu, Ming Zhou, Haohui Fang, Shanqing Li, Minhua Ye, Guowu Wu, Lejie Cao, Jie Jiang, Mingqiang Kang, Haipeng Xu, Xingya Li, Liangming Zhu, Aihong Zhong, Qian Sun, Changli Wang, Haitao Ma, Kaican Cai, Yu Zhang, Xiaochun Zhang, Hong Hu, Jun Chen, Zhixiong Yang, Wengang Zhang, Yunchao Huang, Jian Hu, Liwei Zhang, Jian Yao, Zhiye Zhang, Lunxu Liu, Dongmei Lin, Jie Zhang, Gang Chen, Lei Zhu, Weihua Wang, Jing Xu, Jianjun Zou, Neotorch Investigators, Jinlu Shan, Keneng Chen, Kunshou Zhu, Xiaosheng Hang, Dezhen Cao
| JAMA Network Verified
Key Points Question Does perioperative toripalimab plus chemotherapy improve the surgical outcomes in stage III non–small cell lung cancer (NSCLC)? Findings Among the surgical patients in this phase 3 randomized clinical trial, preoperative toripalimab plus chemotherapy showed significantly improved survival through effective tumor downstaging without new safety signals.
Open in Who Shared Issue with article?
Show More